Please provide your email address to receive an email when new articles are posted on . Postmenopausal women with moderate to severe genitourinary syndrome experienced small but significant increases ...

Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 2008;111:67 ...

Hormone replacement therapy using vaginal estrogen tablets was not associated with an increased risk of ischemic stroke for postmenopausal women who have already had a stroke, according to a data ...

A total of 3353 recurrent cases were identified from a cohort of 56,642 women with a first-time stroke and were matched with 3353 controls. HealthDay News — For women with a history of ischemic stroke ...

Vaginal atrophy is a condition that can negatively impact the quality of life of many postmenopausal women. Local exogenous estrogen therapy can effectively alter the anatomic and pathophysiologic ...

Women with breast cancer who use vaginal estrogen therapies, such as tablets or creams, do not face an increased risk for breast cancer–specific mortality, which can provide some reassurance to ...

BAUDETTE, Minn., Sept. 12, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for ...

NEW YORK (Reuters Health) - An ultra-low dose of 10 micrograms of estradiol significantly improves vaginal tissue, pH balance, and urogenital symptoms in postmenopausal women with vaginal atrophy, new ...

Although both sexes normally secrete some female hormones (estrogens) from birth until death, by far the heaviest output is among women who are old enough to bear children. From early teens to the ...

Exposure to vaginal estradiol not linked to increased rate of recurrent ischemic stroke when adjusted for comorbidity, medications, income, education. (HealthDay News) — For women with a history of ...